Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study-Reference-Cited by-同舟云学术

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study

Published:2021-02-21 Issue:6 Volume:5 Page:938-946
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Barritt A. Sidney¹^ORCID,Watkins Stephanie²^ORCID,Gitlin Norman³,Klein Samuel⁴,Lok Anna S.⁵,Loomba Rohit⁶,Schoen Cheryl²,Reddy K. Rajender⁷^ORCID,Trinh Huy Ngoc⁸,Mospan Andrea R.²^ORCID,Vos Miriam B.⁹,Weiss L. Michael¹⁰,Cusi Kenneth¹¹,Neuschwander‐Tetri Brent A.¹²,Sanyal Arun J.¹³

Affiliation:

1. Division of Gastroenterology and Hepatology UNC Liver CenterUniversity of North Carolina at Chapel Hill Chapel Hill NC USA

2. Target RWE Durham NC USA

3. Atlanta Gastroenterology Associates Atlanta GA USA

4. Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine Washington University School of Medicine St. Louis MO USA

5. Division of Gastroenterology and Hepatology University of Michigan Ann Arbor MI USA

6. Division of Gastroenterology Department of Medicine University of California at San Diego CA USA

7. Division of Gastroenterology and Hepatology University of Pennsylvania Philadelphia PA USA

8. San Jose Gastroenterology San Jose CA USA

9. School of Medicine Emory University Children's Healthcare of Atlanta Atlanta GA USA

10. Gastro Florida Clearwater FL USA

11. Division of Endocrinology, Diabetes and Metabolism University of Florida Gainesville FL USA

12. Division of Gastroenterology and Hepatology Saint Louis University St. Louis MO USA

13. Division of Gastroenterology, Hepatology and Nutrition Department of Internal Medicine Virginia Commonwealth UniversityVCU Medical Center–MCV CampusWest Hospital Richmond VA USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1689

Reference25 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2. Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

3. The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States

4. Nonalcoholic Fatty Liver Disease

5. Diagnosed and Undiagnosed Diabetes Prevalence by County in the U.S., 1999–2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up;Hepatology Research;2024-08-19

2. Update on Newly Federal Drug Administration-Approved Drug, Resmetirom: A Practical Perspective;American Journal of Gastroenterology;2024-06-28

3. High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort;American Journal of Gastroenterology;2024-05-09

4. The role of glucagon‐like peptide‐1 receptor agonists in metabolic dysfunction‐associated steatohepatitis;Diabetes, Obesity and Metabolism;2024-03-21

5. Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease;World Journal of Gastroenterology;2024-03-14